Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
lol its not a cure for cancer....its an effective treatment of tumor cancer that minimizes discomfort. Dog today gets blasted with beams and then does lots of chemotherapy and feels like crap, or, they simply get a single injection of Isopet and has 0 side effects for the same, or less overall cost. Which would you sign your pet up for?
? They issue convertible notes when cash is needed. That is the way pre-revenue biopharma's works. They get whatever they need on demand pretty much. Its these notes that create money/value for investors, who can catch stocks like RDGL under .01 as the noteholder drops off their load. Often the company is very much undervalued when a noteholder sells, which is the opportunity in pinky land. Usually noteholders hire market makers to artificially drop the price so they can convert as well. RDGL never should have gone to .0027. All forced.
These guys are planning to deploy Isopet at any moment. All it takes is 1 clinic to jump on its gangbusters from there.
can't be understated enough that recently the country saw many vet clinics adopt nuclear medicine for Strontium. RDGL's Isopet supercharges what Strontium does. These clinics are equipped to deploy RDGL rapidly. The demonstration phase is about complete here.
https://www.google.com/search?source=hp&ei=4xxVW7_hDLGHmwW1vbyIAw&q=strontium+90+pet+therapy&oq=strontium+90+pet+therapy&gs_l=psy-ab.3...1131.7435.0.7667.27.21.0.0.0.0.594.4005.0j3j7j2j1j1.14.0....0...1.1.64.psy-ab..13.13.3770.0..0j0i131k1j0i22i30k1j33i160k1j33i22i29i30k1.0.0hrp-fGY-d4
RadioGelTM is a hydrogel liquid containing tiny Yttrium-90 phosphate particles to be injected into a tumor. This hydrogel is a liquid at temperatures below body temperature but begins to gel, harden, upon injection as the temperature increases to normal body temperature, thereby locking the particles in place. The particles emit a very high concentrated and contained beta irradiation to kill the tumor. The beta radiation has a short penetration distance so there is minimal collateral damage to healthy tissues outside of the injected area.
https://globenewswire.com/news-release/2018/01/02/1277091/0/en/Advanced-Medical-Isotope-Corporation-ADMD-Announces-Corporate-Name-Change-to-Vivos-Inc-and-Ticker-Symbol-Change-to-RDGL.html
I read somewhere that once they inject this into the tumor, that it hardens and freezes in place, holding the radiation to the tumor without spreading elsewhere. I will have to find it again...its what makes the treatment work so well without toxicity to other organs or area.
Seems to me all systems a-go here as they shared cat data with VCA over the last few months, and are now sharing dog data which started in May and goes through November.
The 5% holders purchased immediately after this
Glad i bought 1.5m i will attempt some ceo update on how may treatments going. Life saving treatment only thing left is to make sure the drug doesnt spread toxicity out of the treatment area. Which it does not if on all accounts. Dosing is key
This is about to get silly
Even note holders have little to no stock. Explosively thin. Do you guys work on news from the ceo? The may teatment updates anticipated to drive this multiples upon multiples
This thing only went below .01 this month sparingly and those got picked up by sched d and g. Its only The beginning of an easy 500 ticks up with only 90 ticks down potential. The last PR talks about data being built as baseline for VCA Marketing and there are likely many small private vet clinics on boarding now Or simply buying stock
that is smoking...those animal trials were successfully done in May
attitude about to turn positive here for a good while it seems could be multi month runner
you guys know what you are doing I like it....ACSM has to cover big here.
who's vca and how do you know?
An asian d filer is always good news
https://www.prosek.com/unboxed-thoughts/another-difference-between-d-and-g-is-more-than-just-the-obvious/
ascm should know this has viral written all over it. 3 or 4 vets onboarding quickly turns into 30 or 40. who's doing all of this buying? not IHUB or any group
considering they just started selling Isopet in the last few days to over 300 Vets there is a good chance you don't know what you are talking about. These people, like most, don't look at a chart. My guess is Asian vets are about to be marketed as well based on the early July filing.
http://find.vetspecialists.com/search_results?page=1&ttid=4&tid=+&location_value=
Was just a preliminary file. I wonder who the strategic partners are
If they are making their commercial push and veterinarians are liking it then this may be why its moving
ACSM in trouble on yet another ticker.
headed to Asia is the idea with this purchase IMO
Residence or business address; Flat H, 13/F, Block 10, Park Island, Hong Kong
it looks to me that they sold 100 producing wells that did $7M rev last 12 months, and are left with about 50 well bores to bring online.
Would think they can get up to $3M or so in rev. But, those guys wouldn't have assumed the $36M in debt unless they thought energy prices were going to rise, hoping the $7M in rev they acquired turns into $10M or more annually. Have to figure a solid $4M or $5M rev company here
what I come up with is they will be getting about $1M in royalties per year cash, have $4M debt left, 15M O/S and brand new leases to work. $15M in NOLS. Whatever those new leases can produce is what the worth is here...
nice site http://www.supremesweetsinc.com/
looks like about a $10M deal? $5M promisarry note and 20% of UHLN https://www.nasdaq.com/press-release/us-highland-cruzani-announces-the-completion-of-supreme-sweets-acquisition-20180711-00344
here we go health insurers breaking past all time highs at the moment...EHTH should break its all 12 month $28 high easily shortly and press toward its all time high of around $55 into end of 2018.
my article brings to light information that even EHTH did not know or address yet with analysts in terms of amount of commission rates increases moving forward...I've pinged all of the analysts to bring it up on the July 26th earnings call and I've emailed the EHTH CEO to get on it.
heading toward all time high whole sector is breaking all time highs and ehth has what it takes to get to $50 now
Price Targets $50, then $100, then $200
https://seekingalpha.com/article/4186073-ehealth-medicare-commissions-grow-company
at the end of the day, I am trying to make money with the company, and also catch the CEO attention...would like to consult for them....
I think its going to take off very shortly...EHTH should be coming out with a PR on the Q2 which is July 26th...I'm hoping they are ready to announce 2019 preview....
13M S.A. readers...42M pageview monthly...hoping to get traction
almost published at S.A. final proofing now preview below...
eHealth (EHTH)-As Medicare Commissions Grow, So Does The Company
Jul. 6, 2018 10:17 AM ET
|
About: eHealth, Inc. (EHTH)
Mark Taylor
Mark Taylor
Growth, medium-term horizon
Summary
•The company is primarily a Medicare Broker Now.
•Profit margins are increasing rapidly.
•Medicare commission expansion could be as much as 50% over the next decade.
E-health (EHTH) is set to double soon and quadruple long term as profitability is back. Small caps are on fire, especially ones like EHTH who have little to no debt.
The company known for helping Individuals and Small Businesses find health plans is now mainly a Medicare Broker, helping seniors and disabled people enroll into various Medicare Plans. Its been this way for a few years now. The thing is, margins have been low and the company has struggled to make profits, but boy, how that is changing.
Commission Rates Rising
Since 2015 the government approved changes pegged to start in 2016 in the way it sets the commission rate that insurers are allowed to pay for Medicare Advantage C and Prescription Drug Plan D renewals. Since then the renewal rates are allowed to float with what they call fair market value, which is fancy for we will allow the insurers to pay you in relation to the total value of the transaction. No matter when you make the sale, 2018 for example, if the rates are higher in 2019 or 2020, then eHealth can get paid more in those renewal years if the plan is still on the books and the insurer honors the government allowed increase. As we all know, the cost of care keeps rising, and thus, the total value of the transaction also keeps rising. Initial payments, which are usually a higher commission, are also set by fair market value. The bottom line is, the government keeps increasing what it pays insurers to administer Part C and Part D, and thus what the insurers are allowed to pay brokers like EHTH keeps rising.
Part C allowable commission is up about 20% since 2015, and Part D allowable commission is up by about 30%. On May 25th 2018, CMS announced the 2019 C and D allowable rates which are up by almost 6% year-over-year in some cases. The insurers have historically paid the maximum allowable, though they are not required too. It's likely that will continue as insurers don't want brokers to leave them behind if they don't pay the maximum allowable.
Table Below Source: Precision Senior Marketing
C and D Allowable Commissions
Table Below Source: CMS
C and D 2019
Margins Set To Rise
Here's the thing, gross margin at EHTH is about 27% on Medicare today. That is small. But, the government has the per capita cost of Medicare care rising by about 4.6% annually for the next 10 year stretch. Simple math says that therefore Medicare C and D commission rates will also rise by about 4.6% annually. That is a whopping 50% rate increase over that timeframe. As anyone with any financial sense knows, if you are doing the same work for a sale, but that sale simply pays you more in the future, your margins will increase. Will EHTH's gross margin on Medicare go from 27% today to 77%? No, some of their Medicare sales, like Medigap plans known as Medicare Supplements (about 25% of their overall Medicare revenue), are not seeing commission rate increases. But, EHTH is also actively working to lower its cost of Medicare sales. They have a target of 40% to 50% margin soon.
The kicker, and this is where you have to pay attention, is that they aim for 40% to 50% gross margin on their own initiatives and are not relying on Commission expansion. They have a deal with Union Plus to help enroll union retirees at a very low cost to them to spike their margins. Union Plus gets a small rev share. In light of the recent Supreme Court ruling, the union bosses have been planning and deploying revenue sharing agreements for services used by union members to raise cash. The ruling heightens the need for Union Plus to push even more of its retirees to EHTH so they can get more revenue sharing. In other words, Wednesday was a win for EHTH and all of the other services that union members use because Union Plus will push their members to these services to get revenue out of it. This is probably a better a business model for the unions going forward to raise cash, but that is another story.
Big Profits Ahead
Using math and the stated Medicare CAGR that EHTH has for its enrollments of 20% through 2020 (I figure it'll slow some after that), the stated 40%+ margin by 2020 (highlighted below) on its own initiatives, and tacking on the 4.6% commission expansion for C and D sales (around 3% for their total Medicare book when you figure their Medicare Supplements sales) you come up with 50% margins within 5 years. You also come up with gross profits of near $300M by 2025 (highlighted below).
Estimates Below Source: My calculations using company 2018 data as baseline
Click to enlargeestimates
It's possible the enrollment growth or commission changes in the future could be less than opined here. There is plenty of regulation out there on Medicare C and D plans and CMS updates it's thinking annually on them. One large item that make occur is that Medicare B drugs may move into Medicare D as President Trump has tasked Health Secretary Alex Azar to do. This would surely raise the cost of Part D and alter the part D program.
With a 19M fully diluted share count, and gross profits possibly over $100M within 2 years, you have to think of $1B valuation or $50 price targets. In fact, I believe their Medicare portal to be worth substantially more than that because as a Medicare Broker myself, I can tell you their online platform is the easiest to use to help my customers find a plan. All they need to do is make their drug portal an app, and tack on an EHTH discount drug card every time they make a sale, and you easily blow away GoodRx and their $3B valuation.
More Than Just Medicare
This is just Medicare folks! I have no idea what they are going to do with their other segments. I've proffered they should dominate the subsidized market as 7M people use Healthcare.gov and pay next to nothing for a health plan. EHTH is set up to enroll folks with a subsidy for individual health. They should do more.
Since many of those plans purchased with a subsidy typically have a high deductible, EHTH should offer at the point of sale a Gap plan that fills in part of that deductible. Some Gap plans, for example, will pay up to 50% of your deductible for medical testing or a hospital stay. If you have a $4000 deductible, then the Gap plan would pay 50% or $2000 toward that deductible each year for a cost of around $40 per month. Make it guaranteed issue so there are no medical questions, and they can double their commission. Ever buy an airline ticket and you have the option to toggle on a Trip Cancellation plan? Healthcare.gov will never be able to sell those folks a Gap plan that they desperately need. I believe their subsidized market could be easily another $500M to $1B in value if they invest into it once they get cashflow rolling in Medicare, which, they are cashflow positive right about now.
The stock recently had a Golden Cross (50MA moved over the 200MA). Its a bullish sign. Look for a break of $28, which is the high of the past 12 months, for more bullishness. Don't be afraid of Option Calls if you are not into playing the small cap space with big money. Tip-toe in with some $25 or $30 calls heading into 2019.
Disclosure: I am/we are long EHTH.
I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.
sent it to all of the analysts and the CEO..the CEO sent me a LinkedIn Request..LOL. S.A. got back to me...I have to put some links in and such....if I have time I may update it this week....well let you guys know if it gets published.
hoping to get published in S.A.
EHTH-A New Era
hoping to get published on Seeking Alpha...
Summary
•Primarily a Medicare Broker Now.
•Record Medicare Enrollment.
•Medicare Commissions Growing Rapidly.
The company known for helping Individuals and Small Businesses find health plans is now mainly a Medicare Broker, helping seniors and disabled people enroll into various Medicare Plans. Its been this way for a few years now. The thing is, margins have been low and the company has struggled to make profits, but boy, how that is changing.
In 2015 the government changed the way it sets the commission rate that insurers are allowed to pay for Medicare C and Medicare D plans. Since then the rates are set by what they call Fair Market Value, which is fancy for we will allow the insurers to pay you in relation to the total value of the transaction. As we all know, the cost of care keeps rising, and thus, the total value of the transaction also keeps rising. The bottom line is, the government keeps increasing what it pays insurers to administer Part C and Part D, and thus what the insurers are allowed to pay brokers like EHTH keeps rising.
Part C allowable commission is up about 20% since 2015, and Part D allowable commission is up by about 30%. The insurers have historically paid the maximum allowable, though they are not required too. It's likely that will continue as insurers don't want brokers to leave them behind if they don't pay the maximum allowable.
Here's the thing, gross margin at EHTH is about 27% on Medicare today. That is small. But, the government has the cost of care rising by about 5.5% annually through 2026. Simple math says that therefore Medicare C and D commission rates will also rise by about 5.5% annually. That is a whopping 50% rate increase over the next 8 years. As anyone with any financial sense knows, if you are doing the same work for a sale, but that sale simply pays you more in the future, your margins will increase. Will EHTH's gross margin on Medicare go from 27% today to 77% in the next 8 years? No, because they will have some cost rises. But, EHTH is also actively working to lower its cost of Medicare sales. They have a target of 40% to 50% margin soon.
The kicker, and this is where you have to pay attention, is that they aim for 40% to 50% gross margin on their own initiatives and are not relying on Commission expansion. They have a deal with Union Plus to help enroll union retirees at a very low cost to them to spike their margins. Union Plus gets a small rev share. In light of this weeks Supreme Court ruling, the union bosses have been planning and deploying revenue sharing agreements for services used by union members to raise cash. The Wednesday ruling heightens the need for Union Plus to push even more of its retirees to EHTH so they can get more revenue sharing. In other words, Wednesday was a win for EHTH and all of the other services that union members use because Union Plus will push their members to these services to get revenue out of it. This is probably a better a business model for the unions going forward to raise cash, but that is another story.
Using math and the stated Medicare CAGR that EHTH has for its enrollments of 20% for the next few years, and tacking on the 5.5% commission expansion for C and D sales (about 75% of their total revenue) you come up with 40% margins within 2 years, 50% margins within 4, and 60% margins within 6. You also come up with gross profits of $50M in 2018, $70M in 2019, and over $100M in 2020. By 2026 you come up with gross profits near $300M.
With a 19M fulling diluted share count, and gross profits of $100M within 2 years, you have to think of $1B valuation or $50 price targets. In fact, I believe their Medicare portal to be worth substantially more than that because as a Medicare Broker myself, I can tell you their online platform is the easiest to use to help my customers find a plan. All they need to do is make their drug portal an app, and tack on an EHTH discount drug card every time they make a sale, and you easily blow away GoodRx and their $3B valuation.
This is just Medicare folks! I have no idea what they are going to do with their other segments. I've proffered they should dominate the subsidized market as 7M people use Healthcare.gov and pay next to nothing for a health plan. EHTH is set up to enroll folks with a subsidy for individual health. They should do more. Since many of those plans purchased with a subsidy typically have a high deductible, EHTH should offer at the point of sale a Gap plan that fills in part of that deductible. Make it guaranteed issue so there are no medical questions, and they can double their commission. Ever buy an airline ticket and you have the option to toggle on a Trip Cancellation plan? Healthcare.gov will never be able to sell those folks a Gap plan that they desperately need. I believe their subsidized market could be easily another $500M to $1B in value if they invest into it once they get cashflow rolling in Medicare, which, they are cashflow positive right about now and Launch Control is here.
Disclosure: I am/we are long EHTH.
I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.
Medicare Outlook EHTH. Even put a 10% constraint on all if you want...Long Term riser here
2018 185M Gross 50M Net 10M 25% enrollment growth 3% commission rise
2019 227M Gross 70M Net 30M 20% enrollment growth 3% commission rise
2020 277M Gross 95M Net 55M 20% enrollment growth 3% commission rise
2021 313M Gross 115M Net 85M 10% enrollment growth 3% commission rise
2022 353M Gross 150M Net 115M 10% enrollment growth 3% commission rise
2023 398M Gross 175M Net 145M 10% enrollment growth 3% commission rise
2024 449M Gross 205M Net 170M 10% enrollment growth 3% commission rise
2025 507M Gross 240M Net 205M 10% enrollment growth 3% commission rise
19M O/S Net 205M 15PE $3B Value
EHTH-A New Era
hoping to get published on Seeking Alpha...
Summary
•Primarily a Medicare Broker Now.
•Record Medicare Enrollment.
•Medicare Commissions Growing Rapidly.
The company known for helping Individuals and Small Businesses find health plans is now mainly a Medicare Broker, helping seniors and disabled people enroll into various Medicare Plans. Its been this way for a few years now. The thing is, margins have been low and the company has struggled to make profits, but boy, how that is changing.
In 2015 the government changed the way it sets the commission rate that insurers are allowed to pay for Medicare C and Medicare D plans. Since then the rates are set by what they call Fair Market Value, which is fancy for we will allow the insurers to pay you in relation to the total value of the transaction. As we all know, the cost of care keeps rising, and thus, the total value of the transaction also keeps rising. The bottom line is, the government keeps increasing what it pays insurers to administer Part C and Part D, and thus what the insurers are allowed to pay brokers like EHTH keeps rising.
Part C allowable commission is up about 20% since 2015, and Part D allowable commission is up by about 30%. The insurers have historically paid the maximum allowable, though they are not required too. It's likely that will continue as insurers don't want brokers to leave them behind if they don't pay the maximum allowable.
Here's the thing, gross margin at EHTH is about 27% on Medicare today. That is small. But, the government has the cost of care rising by about 5.5% annually through 2026. Simple math says that therefore Medicare C and D commission rates will also rise by about 5.5% annually. That is a whopping 50% rate increase over the next 8 years. As anyone with any financial sense knows, if you are doing the same work for a sale, but that sale simply pays you more in the future, your margins will increase. Will EHTH's gross margin on Medicare go from 27% today to 77% in the next 8 years? No, because they will have some cost rises. But, EHTH is also actively working to lower its cost of Medicare sales. They have a target of 40% to 50% margin soon.
The kicker, and this is where you have to pay attention, is that they aim for 40% to 50% gross margin on their own initiatives and are not relying on Commission expansion. They have a deal with Union Plus to help enroll union retirees at a very low cost to them to spike their margins. Union Plus gets a small rev share. In light of this weeks Supreme Court ruling, the union bosses have been planning and deploying revenue sharing agreements for services used by union members to raise cash. The Wednesday ruling heightens the need for Union Plus to push even more of its retirees to EHTH so they can get more revenue sharing. In other words, Wednesday was a win for EHTH and all of the other services that union members use because Union Plus will push their members to these services to get revenue out of it. This is probably a better a business model for the unions going forward to raise cash, but that is another story.
Using math and the stated Medicare CAGR that EHTH has for its enrollments of 20% for the next few years, and tacking on the 5.5% commission expansion for C and D sales (about 75% of their total revenue) you come up with 40% margins within 2 years, 50% margins within 4, and 60% margins within 6. You also come up with gross profits of $50M in 2018, $70M in 2019, and over $100M in 2020. By 2026 you come up with gross profits near $300M.
With a 19M fulling diluted share count, and gross profits of $100M within 2 years, you have to think of $1B valuation or $50 price targets. In fact, I believe their Medicare portal to be worth substantially more than that because as a Medicare Broker myself, I can tell you their online platform is the easiest to use to help my customers find a plan. All they need to do is make their drug portal an app, and tack on an EHTH discount drug card every time they make a sale, and you easily blow away GoodRx and their $3B valuation.
This is just Medicare folks! I have no idea what they are going to do with their other segments. I've proffered they should dominate the subsidized market as 7M people use Healthcare.gov and pay next to nothing for a health plan. EHTH is set up to enroll folks with a subsidy for individual health. They should do more. Since many of those plans purchased with a subsidy typically have a high deductible, EHTH should offer at the point of sale a Gap plan that fills in part of that deductible. Make it guaranteed issue so there are no medical questions, and they can double their commission. Ever buy an airline ticket and you have the option to toggle on a Trip Cancellation plan? Healthcare.gov will never be able to sell those folks a Gap plan that they desperately need. I believe their subsidized market could be easily another $500M to $1B in value if they invest into it once they get cashflow rolling in Medicare, which, they are cashflow positive right about now and Launch Control is here.
Disclosure: I am/we are long EHTH.
I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.
Medicare Outlook EHTH. Even put a 10% constraint on all if you want...Long Term riser here
2018 185M Gross 50M Net 10M 25% enrollment growth 3% commission rise
2019 227M Gross 70M Net 30M 20% enrollment growth 3% commission rise
2020 277M Gross 95M Net 55M 20% enrollment growth 3% commission rise
2021 313M Gross 115M Net 85M 10% enrollment growth 3% commission rise
2022 353M Gross 150M Net 115M 10% enrollment growth 3% commission rise
2023 398M Gross 175M Net 145M 10% enrollment growth 3% commission rise
2024 449M Gross 205M Net 170M 10% enrollment growth 3% commission rise
2025 507M Gross 240M Net 205M 10% enrollment growth 3% commission rise
19M O/S Net 205M 15PE $3B Value
Hiiq straight up as ehth should. Blame management for not informing of how ehth shares rev with unions and this is how unions raise cash lost by losing fees. Union plus gonna send all retirees to ehth. Union plus will send all union members to all of its partners for rev share